Axis Capital

Investing

Akums Drugs and Pharamaceuticals IPO Oversubscribed 63.5 Times, Strong Market Debut Expected

Akums Drugs and Pharmaceuticals, a leading name in the Indian pharmaceutical industry, is poised for its much-anticipated debut on the stock exchanges this Tuesday. With a robust subscription rate and a significant Grey Market Premium (GMP), the company’s initial public offering (IPO) has garnered substantial investor interest. Here are five key points about Akums’ IPO and its market debut: Strong…